Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows used in operating activities:
Net loss	$ (3,258,955)	$ (4,070,457)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	103,545	229,423
Amortization of right-of-use assets	13,451	39,409
Amortization of debt issuance costs		15,188
Stock based compensation	426,281	123,500
Provision for accounts receivable allowances	(29,741)	71,379
Vendor liability forgiveness, net of asset transfers	2,364,954
Changes in operating assets and liabilities:
Accounts receivable	709,383	(507,733)
Inventories	404,299	2,648,710
Prepaid expenses and other current assets	6,936	(81,248)
Other assets	15,184	8,410
Accounts payable	(3,157,987)	2,498,991
Accrued expenses	(66,164)	288,307
Deferred revenue		121,401
Operating lease liabilities	(13,451)	(39,409)
Net cash provided by (used in) operating activities	(2,482,265)	1,345,871
Cash flows from investing activities:
Purchases of equipment		(6,330)
Certification costs capitalized		(122,120)
Net cash used in investing activities		(128,450)
Cash flows from financing activities:
Net proceeds from the bank credit line		(945,441)
Proceeds from preferred stock issuance	2,800,000
Net cash provided by financing activities	2,800,000	(945,441)
Net increase in cash and cash equivalents	317,735	271,980
Cash and cash equivalents - Beginning	709,322	1,030,110
Cash and cash equivalents - Ending	1,027,057	1,302,090
Cash paid during the period for:
Interest		103,950
Income taxes
Cash and cash equivalents	1,027,057	802,090
Restricted cash		500,000
Total cash, cash equivalents and restricted cash	$ 1,027,057	$ 1,302,090